Levy Michael L, Wang Michael, Aryan Henry E, Yoo Kevin, Meltzer Hal
Department of Neurosurgery, University of California, San Diego, and Children's Hospital of San Diego, San Diego, California , USA.
Neurosurgery. 2003 Nov;53(5):1138-44; discussion 1144-5. doi: 10.1227/01.neu.0000089060.65702.03.
The optimal surgical treatment for symptomatic temporal arachnoid cysts is controversial. Therapeutic options include cyst shunting, endoscopic fenestration, and craniotomy for fenestration. We reviewed the results for patients who were treated primarily with craniotomy and fenestration at our institution, to provide a baseline for comparisons of the efficacies of other treatment modalities.
A retrospective review of data for 50 children who underwent keyhole craniotomy for fenestration of temporal arachnoid cysts between 1994 and 2001 was performed after institutional review board approval. During that period, the first-line treatment for all symptomatic middle fossa arachnoid cysts was microcraniotomy for fenestration. Microsurgical dissection to create communications between the cyst cavity and basal cisterns was the goal. All patient records were reviewed and numerous variables related to presentation, cyst size and classification, treatment, cyst resolution, symptom resolution, follow-up periods, and cyst outcomes were recorded.
Fifty temporal arachnoid cysts in 50 treated patients were identified. The average age at the time of surgery was 68 +/- 57.2 months. The follow-up periods averaged 36 months. There were 34 male and 16 female patients in the series. Twenty-six cysts were on the left side. Indications for surgery included intractable headaches (45%), increasing cyst size (21%), seizures (25%), and hemiparesis (8%). The symptoms most likely to improve were hemiparesis (100%) and abducens nerve palsies. Headaches (67%) and seizure disorders (50%) were less likely to improve. Nine patients exhibited progressive increases in cyst size in serial imaging studies. Those patients were monitored for a mean of 40 +/- 23 months before intervention. In the entire series, 82% of patients demonstrated decreases in cyst size in serial imaging studies. Of those patients, 18% demonstrated complete cyst effacement. Overall, 83% of patients with Grade II cysts and 75% of patients with Grade III cysts exhibited evidence of decreases in cyst size in long-term monitoring. Two patients required shunting after craniotomy (4%). Hospital stays averaged 3.4 days. Total surgical times averaged 115 minutes. No significant blood loss occurred (5-50 ml). Complications included spontaneously resolving pseudomeningocele (10%), transient Cranial Nerve III palsy (6%), cerebrospinal fluid leak (6%), subdural hematoma (4%), and wound infection (2%).
A microsurgical keyhole approach to arachnoid cyst fenestration is a safe effective method for treating middle fossa cysts. This procedure can be performed with minimal morbidity via a minicraniotomy. Compared with an endoscopic approach, better control of hemostasis can be obtained, because of the ability to use bipolar forceps and other standard instruments. The operative time and length of hospital stay were not excessively increased.
有症状的颞叶蛛网膜囊肿的最佳手术治疗方法存在争议。治疗选择包括囊肿分流术、内镜下开窗术和开颅开窗术。我们回顾了在本机构主要接受开颅开窗术治疗的患者的结果,以提供一个用于比较其他治疗方式疗效的基线。
在获得机构审查委员会批准后,对1994年至2001年间接受锁孔开颅术治疗颞叶蛛网膜囊肿开窗的50例儿童的数据进行了回顾性分析。在此期间,所有有症状的中颅窝蛛网膜囊肿的一线治疗方法是显微开颅开窗术。目标是通过显微手术分离在囊肿腔和基底池之间建立连通。审查了所有患者的记录,并记录了与临床表现、囊肿大小和分类、治疗、囊肿消退、症状缓解、随访时间以及囊肿转归相关的众多变量。
在50例接受治疗的患者中发现了50个颞叶蛛网膜囊肿。手术时的平均年龄为68±57.2个月。随访时间平均为36个月。该系列中有34例男性和16例女性患者。26个囊肿位于左侧。手术指征包括顽固性头痛(45%)、囊肿增大(21%)、癫痫发作(25%)和偏瘫(8%)。最有可能改善的症状是偏瘫(100%)和外展神经麻痹。头痛(67%)和癫痫障碍(50%)改善的可能性较小。9例患者在系列影像学研究中囊肿大小呈进行性增加。这些患者在干预前平均监测了40±23个月。在整个系列中,82%的患者在系列影像学研究中囊肿大小减小。其中,18%的患者囊肿完全消失。总体而言,83%的II级囊肿患者和75%的III级囊肿患者在长期监测中显示囊肿大小有减小的迹象。2例患者在开颅术后需要分流(4%)。平均住院时间为3.4天。总手术时间平均为115分钟。无明显失血(5 - 50毫升)。并发症包括自行消退的假性脑膜膨出(10%)、短暂性动眼神经麻痹(6%)、脑脊液漏(6%)、硬膜下血肿(4%)和伤口感染(2%)。
蛛网膜囊肿开窗的显微手术锁孔入路是治疗中颅窝囊肿的一种安全有效的方法。该手术可通过微型开颅术以最小的发病率进行。与内镜入路相比,由于能够使用双极镊和其他标准器械,可以更好地控制止血。手术时间和住院时间没有过度增加。